FSANZ Drafts Food Approval for GM Wheat as Cultivation Review Continues
Australia and New Zealand’s food regulator has drafted permission for food made from a genetically modified wheat line engineered to contain more nicotianamine, while a separate decision on whether the crop can be grown commercially in Australia remains unfinished.
The Food Standards Australia New Zealand consultation opened on 20 October 2026 and closes on 1 December. FSANZ says its assessment found no food-safety concerns and that food from wheat line UM-12115T-1 is as safe as food from conventional wheat. That is a draft food-code decision, not a cultivation licence or a commercial launch.
For grain handlers, millers and food manufacturers, the important distinction is regulatory sequence. A food permission would establish how material from the crop may enter the food chain and when genetically modified labelling is required. It would not by itself allow Australian farmers to plant the wheat.
What the draft decision would—and would not—permit
The application, submitted by the University of Melbourne, seeks a new entry in the Australia New Zealand Food Standards Code for food derived from the modified wheat. The line is intended primarily for animal feed, but FSANZ’s documents acknowledge that grain could enter human food through shared processing infrastructure or if surplus feed grain is redirected.
If the variation is ultimately approved, foods would require genetic-modification labelling where novel DNA or novel protein remains in the final product. Australia and New Zealand’s existing exemption for unintended presence at no more than 1% of an ingredient would continue to apply. Highly refined products in which novel DNA and protein are absent may be treated differently under the code’s existing rules.
Commercial growing is a separate gate. The Office of the Gene Technology Regulator is assessing application DIR 227 for possible Australia-wide cultivation, subject to state and territory rules. OGTR says public consultation on its risk assessment and risk-management plan is expected in December 2026. Cultivation in New Zealand would require separate approval from the Environmental Protection Authority.
Neither regulator’s public material establishes a commercial planting date, contracted acreage, processing customer or expected retail product. Those omissions matter: a favourable food decision would remove one regulatory barrier, but seed multiplication, variety development, agronomic performance, segregation arrangements and buyer acceptance would still determine whether the trait moves beyond trials.
The trait changes nicotianamine, not total iron and zinc
UM-12115T-1 contains the rice OsNAS2 gene, which increases production of nicotianamine. Plants use this molecule to bind and transport metals. The application’s theory is that a higher nicotianamine concentration in grain may improve mineral bioavailability, a claim that would require evidence beyond showing the compound is present.
The regulator’s compositional finding is narrower than a simple “iron-rich wheat” description. FSANZ reported that nicotianamine was consistently elevated across the tested environments but remained within the range it identified for conventional wheat. It found no statistically significant difference in total iron or zinc concentration between the modified line and its near-isogenic control.
FSANZ therefore expects the wheat to make a negligible difference to population nutrient intake. That conclusion does not say nicotianamine has no biological role; it says the submitted food-composition evidence does not support treating this line as a material source of additional iron or zinc at population level.
What the safety assessment examined
The FSANZ supporting safety assessment describes grain grown at four New South Wales sites in 2025: Moama, Binya and two locations at Leeton. The modified wheat was compared with a near-isogenic control and two commercial reference varieties. An accredited third-party laboratory measured 68 grain components, including proximates, amino acids, fatty acids, minerals, vitamins and antinutrients.
Three analytes—thiamine, histidine and phenylalanine—were statistically different from the near-isogenic control, but FSANZ said all three values were within natural ranges reported for wheat. It found no heavy-metal difference that raised a safety concern and no nutritionally meaningful compositional change apart from the intended nicotianamine increase.
The dossier also included two 42-day broiler feeding studies. FSANZ reported no significant difference in bird weight or feed-conversion ratio between diets containing grain from the modified wheat and comparator diets. These are animal-performance studies supporting the food-and-feed dossier; they are not substitutes for OGTR’s environmental assessment of commercial cultivation.
FSANZ also reviewed the introduced proteins, updated searches for similarity to known allergens and toxins, and considered the antibiotic-resistance marker proteins used during transformation. OGTR identifies those markers as hph, derived from Escherichia coli, and nptIII, derived from Enterococcus faecalis. Their presence is part of the regulator’s molecular and safety review, not evidence that the wheat is commercially deployed.
Why processors and grain handlers should care
The practical issue is identity preservation. A crop designed mainly for feed can still touch food channels when elevators, silos, trucks and mills serve both markets. If commercial cultivation is later approved, handlers would need contract terms, cleaning protocols, sampling plans and traceability that match customer specifications and the food code’s labelling threshold.
FSANZ says the application supplies sufficient DNA sequence information to develop a polymerase-chain-reaction method for detection. That gives regulators and supply-chain laboratories a technical starting point, but public documents do not yet describe a standardized commercial test, who would pay for routine testing or how grain buyers would set acceptance limits.
Trade effects are similarly conditional. FSANZ’s draft assessment says the food-code change is unlikely to have a significant effect on international trade and does not require a World Trade Organization notification. In practice, market access would also depend on approvals and customer policies in destination countries, especially if Australian production proceeds before all major buyers recognize the event.
The regulatory gate still ahead
FSANZ is seeking evidence and comments before its board decides whether to approve the variation. The A1356 application page contains the call for submissions, the supporting assessment and the applicant’s dossier. Submissions close at 6 p.m. Canberra time on 1 December 2026.
The next useful signals will be whether the draft food permission changes after consultation, how OGTR evaluates gene flow and environmental risks, and whether commercial developers disclose agronomic performance, stewardship plans and buyer commitments. Until then, the scientifically accurate description is high-nicotianamine GM wheat under parallel food and cultivation review—not an approved biofortified wheat product.
Methodology and sources
Agrilinkage reviewed FSANZ’s 20 October 2026 notice, its call for submissions, the supporting food-safety assessment and the applicant material, together with OGTR’s DIR 227 project page and regulator Q&A. This report distinguishes the food-code process from the cultivation process and does not rely on interviews or field observations.
Comments